We report here the complete amino acid sequence of another member ofthe type (3 transforming growth factor gene family, deduced from the nucleotide sequence of three overlapping cDNA clones. The C-terminal 112 amino acids share '80% sequence identity with type j1 and (2 transforming growth factors, with many of the remaining differences being conservative substitutions. By analogy to type
j1 and type (32 transforming growth factors, we predict the protein to be synthesized as a 412 amino acid precursor that undergoes proteolytic cleavage to produce the mature polypeptide.
In contrast to the rapid accumulation of information over the past few years regarding positive regulators of cell growth (1) (2) (3) , only limited progress has been made in efforts to identify regulatory factors that maintain tissue homeostasis by means of growth inhibition. Two growth inhibitors that have been the focus of considerable attention in recent years are transforming growth factor types (31 and (32 (TGF-,31 and TGF-,32).
TGF-,/1 was first identified by its ability to induce colony formation of certain rodent cell lines in soft agar (4, 5) .
Subsequently, however, TGF-,31 was found to act as a potent growth inhibitor of a variety of cell lines (6) . Both TGF-/31 and -j32 are synthesized as precursors that undergo dimerization and proteolytic cleavage to produce the biologically active polypeptide. In their mature forms, which consist of the C-terminal 112 amino acids, TGF-(31 and -,(2 exhibit 71% sequence identity. TGF-(Bs have been proposed to effect tissue repair, wound healing, bone formation, and embryonic development (7) (8) (9) . Abnormalities in TGF-(3 function have been implicated in both immunosuppression and cellular transformation (8) . In analyzing human tissues and cell lines as potential sources of tumor inhibitory factors, we discovered that extracts from umbilical cord contain multiple growth inhibitory activities, which we termed tissue-derived growth inhibitors (TGIs) (10) . One of these TGI activities was purified to homogeneity and appeared to be indistinguishable from TGF-,81, whereas the initial characterization of a second TGI revealed a distinct but closely related protein. Conventional purification of this activity provided only limited quantities of material for analysis. An alternative strategy was to isolate the cDNA sequences for this TGIt using TGF-(31 cDNA as a probe, predicting that the inhibitor could possess sequence similarity to TGF-, 31. MATERIALS AND METHODS Oligonucleotide Synthesis. Oligonucleotides, synthesized by the phosphoramidite method with an Applied Biosystems (Foster City, CA) model 380 A synthesizer used as specified by the manufacturer, were purified by polyacrylamide gel electrophoresis and desalted on a Waters SEP-PAK C18 cartridge.
DNA Labeling and Hybridization Methods. Nick-translation of DNA restriction fragments and filter hybridizations were done as described (11) . The specific activities of the probes were >2.5 x 108 cpm/pg. Oligonucleotides were phosphorylated using [y-32P]ATP and T4 polynucleotide kinase (12) . Specific activities were >2 x 106 cpm/pmol. Filters were prehybridized for 2 hr in 2.5 x SSC (1 x SSC = 0.15 M sodium chloride/0.015 M sodium citrate, pH 7)/10 x Denhardt's solution (1 x Denhardt's solution = 0.02% polyvinylpyrrolidone/0.02% Ficoll/0.02% bovine serum albumin)/0.1% NaDodSO4, followed by 2 hr at 650C in hybridization mixture [5 x SSC/50 mM sodium pyrophosphate/10 x Denhardt's solution/l0o dextran sulfate/single-stranded DNA at 250.ug/ml/7% (wt/vol) NaDodSO41. Hybridization with the labeled oligonucleotide probes was performed overnight in hybridization mixture at 450C. The filters were washed with 3 x SSC/10 x Denhardt's solution/0.5% NaDodSO4 and exposed to Kodak XAR-2 film at -700C with a DuPont Lightning Plus intensifying screen.
Construction of a cDNA Library from the Human A673 Rhabdomyosarcoma Cell Line. Poly(A)+ RNA was prepared from A673 cells (CRL 1598, American Type Culture Collection) by twice passing total RNA, isolated by the lithium chloride method (13) , over an oligo(dT)-cellulose column (14) . Before cDNA synthesis, the RNA was treated with RNase-free DNase (Promega Biotec, Madison, WI) in the presence of the ribonuclease inhibitor RNasin (Promega Biotec). Starting with 5 u.g of poly(A)+ RNA, a randomprimed cDNA library of approximately 2 x 106 clones was constructed in AgtlO, with the Amersham cDNA Synthesis System Plus according to the manufacturer's procedures [which are based on the method ofGubler and Hoffman (15) ].
Subcloning and DNA Sequencing. EcoRI inserts from positive clones were subcloned in both orientations either in M13 sequencing vectors or in pGEM vectors (Promega Biotec) from which deletion clones were generated by Exonuclease III digestion (16) . Sequencing was done according to the dideoxynucleotide chain-termination method (17) .
RNA Analysis. Poly(A)+ RNA was purified by oligo(dT)cellulose chromatography of total RNA isolated from umbilical cord and various cell lines by the lithium chloride method (13) . Ten micrograms of poly(A) + RNA were fractionated on a 1% agarose gel in the presence of formaldehyde and then transferred to nitrocellulose (12) . Radioactive labeling of the probes was done by the random-priming method (18) . Blots Abbreviation: TGI, tissue-derived growth inhibitor; TGF-,Bl, -P2, and -p3, transforming growth factor type 81, type p2, and type 83, respectively. *To whom reprint requests should be addressed. tThe sequence reported in this paper is being deposited in the EMBL/GenBank data base (IntelliGenetics, Mountain View, CA, and Eur. Mol. Biol. Lab., Heidelberg) (accession no. J03241).
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. were prehybridized in 50% (vol/vol) formamide/50 mM sodium phosphate, pH 6.5/5 x SSC/2.5 x Denhardt's solution/salmon sperm DNA at 250 ,ug/ml/poly(A) at 10 tug/ml for 4 hr at 550C. Hybridization was performed in prehybridization mix/50%o (wt/vol) dextran sulfate, 4:1, for 12 hr at 550C. The filters were washed in SSC buffered with 20 mM sodium phosphate, pH 6.5/1 mM EDTA/0.1% NaDodSO4. Six 20-min washes were carried out at 650C, stepwise lowering the concentration of SSC from 0.3 x to 0.1 x to 0.03 x. Filters were exposed to Kodak XAR-2 film with a DuPont Lightning Plus intensifying screen at -700C.
RESULTS AND DISCUSSION
Identification and Sequence Analysis of a TGI cDNA. Based on the published sequence of TGF-j31 cDNA (19) , we synthesized a 25-mer oligonucleotide (5' CGGCACCGCC-GAGCCCTGGACACCA 3', bases 826-851 of the coding region). This probe was then used to identify a TGF-P31 cDNA clone in a commercial Agtll human placenta library (Clontech, Palo Alto, CA). By restriction mapping and partial sequence analysis, the clone was shown to contain the complete coding sequence for the 390-amino acid TGF-f31 precursor but to lack parts of the untranslated regions [439 base pairs (bp) from the 5' end and -200 bp from the 3' end, data not shown). A Pvu II-Pvu II fragment of the TGF-P1 cDNA was then used as a hybridization probe for a Southern blot (20) of human umbilical cord genomic DNA, digested with EcoRI, HindIII, or Sst I (Fig. 1 ). In each digest two bands were apparent at low stringency (2.5x SSC, 650C, lanes 1, 3, and 5); when the stringency was increased, only one hybridizing band remained visible (0.01 x SSC, 650C, lanes 2, 4, and 6). We presumed that the strongly hybridizing band corresponded to TGF-,81, whereas the detection of a weakly hybridizing second band suggested the presence of a related gene. Both genes were cloned by screening a genomic phage library constructed from the human K-562 chronic myelogenous leukemia cell line according to the procedures of Grosveld et al. (21) . By varying the wash stringency, the TGF-f3 sequences could be distinguished from the TGF-f3related sequences. Restriction mapping and partial sequence analysis revealed that clones hybridizing at high stringency were derived from the gene encoding TGF-,B1, whereas a clone that hybridized only at low stringency appeared to be derived from a related gene. We have termed this DNA sequence TGF-,B3 in the remainder of the text (see discussion below).
To obtain a repeat-free probe for TGF-,83, restriction fragments of the genomic clone were separated by electrophoresis, transferred to nitrocellulose, and then hybridized with either TGF-/31 cDNA or total human genomic DNA. A BamHI-Taq I fragment was found to hybridize specifically to 1 TGF-f31 cDNA, indicating the presence of coding sequence and the absence of repetitive DNA elements. This repeat-free probe was used to screen a Agtll human placenta cDNA library (Clontech, 1.2 x 106 independent clones) resulting in the isolation of a 1.7-kilobase (kb) cDNA clone (Fig. 2 ). Screening of a Agtll human umbilical cord cDNA library (Clontech, 1.5 x 106 independent clones) with a 5' EcoRI-Bgl II restriction fragment ( Fig. 2 , indicated as E-B), derived from the placenta cDNA clone, resulted in the isolation of a 1.9-kb cDNA. The nucleotide sequences of these two cDNA clones confirmed that both were derived from the same gene as the genomic TGF-,83 clone. On RNA analysis, however, the TGF-,33 mRNA was found to be -3.5 kb, indicating that we had not obtained a full-length cDNA.
To obtain a full-length clone, mRNA was isolated from A673 cells, and a cDNA library was prepared by random priming. Approximately 0.7 x 106 unamplified cDNA clones were screened with a 25-mer oligonucleotide probe (5' ATATAGCGCTGTTTGGCAATGTGCT 3', corresponding to a sequence near the 5' end of the 1.9-kb cDNA clone), and a single positive clone containing a 1.7-kb insert was identified.
Analysis of the three overlapping cDNAs (Fig. 2 ) revealed a sequence of 2529 bp, with the largest open reading frame being 1236 bases. We found no sequence differences in the overlapping regions and conclude that all three clones were derived from transcripts of the same gene. Our sequence contains a complete 3' untranslated region of 1031 bp with a polyadenylylation signal 25 bp upstream from the poly(A) tract. The 5' untranslated region comprises 262 bp and lacks -1 kb, as judged from the size of the mRNA estimated by RNA analysis. The predicted amino acid sequence ofTGF-f33
shows extensive similarity to TGF-,B1 and -,32 (19, 22) . Failure of the TGF-,B1 probe to detect TGF-,32 in the original Southern hybridization ( Fig. 1 ) can be accounted for by the fact that the Pvu II-Pvu II TGF-,31 cDNA fragment shows 75% similarity with TGF-,33 but only 65% similarity with TGF-f32. Comparing TGF-f33 with the GenBank 48.0 nucleotide sequence data basel using the FASTN program (23) revealed no significant similarity with genes other than known members (see below) of the TGF-,B family.
A Comparison of TGF-(31, -/32, and -/83. TGF-,81 and TGF-,B2 are produced in precursor forms of 390 and 414 amino acid residues, respectively (19, 22) . The cDNA sequence we have obtained for TGF-,B3 (Fig. 2b) contains an open reading frame coding for 412 amino acids, with the first ATG preceded by a stop codon, 162 nucleotides upstream.
As found with TGF-,B1 (19) and -,82 (22) , the predicted initiating codon for TGF-f33 does not form part of a Kozak consensus sequence (24) . Interestingly, six nucleotides downstream there is a second ATG, with an adenine at position -3, which aligns with the initiating codon in TGF-f32. Homodimers of the C-terminal 112 residues of TGF-,31 and -(82 represent the biologically active forms of these proteins. Preceding the site of cleavage to their mature forms, TGF-,B1 and -/32 have stretches of four and five basic residues, respectively. In TGF-,33 there are five basic residues preceding the predicted cleavage site (Fig. 3) . The mature forms of TGF-f31 and -,(2 share 80/112 identical residues. The corresponding 112 C-terminal amino acids of TGF-p83 exhibit 86/112 and 89/112 identical residues compared with TGF-,l31 and -(32, respectively (Fig. 3) . Many remaining differences represent conservative substitutions. All three proteins show a strict conservation of the nine cysteine residues in this region (19, 22) showing the greatest similarity to TGF-,B1 and -,B2. The 5' EcoRI-Bgl II restriction fragment of the placental cDNA used to screen the umbilical cord library is indicated by a thick bar (E-B). (B) Nucleotide sequence and deduced amino acid sequence of a TGF-/33 cDNA, determined from three overlapping cDNA clones. Putative glycosylation sites and the polyadenylylation signal are underlined. The predicted start of the mature TGF-P3 is marked by an asterisk at position 1164. similarity with TGF-/31 and 45% similarity with TGF-,82. By extracellular matrix and wound healing (8) , it is tempting to comparison, the corresponding sequences of the TGF-ll and speculate that TGF-j33 may also have therapeutic applica--,B2 precursors have 33% sequence similarity (Fig. 3) . A tions in this area. homology matrix plot clearly illustrates the greater similarity Expression of TGF-P3 mRNA. The availability of a TGF-,83 between TGF-p3 and -p62 compared with TGF-f31 (Fig. 3) . cDNA clone allowed us to investigate expression of the gene Four potential glycosylation sites are contained in the N-in different human cell types. Hybridizing mRNA was found terminal part of TGF-f33, one of which is conserved in all to be present in A673 (a rhabdomyosarcoma), A549 (a lung three proteins. All three proteins also possess hydrophobic N adenocarcinoma), and A-498 (a kidney carcinoma); exprestermini, which probably represent presecretory signal pep-sion of TGF-P3 was found to be lower by at least a factor of tide sequences (25) . Interestingly, both TGF-/31 and TGF-/33 50 than that of TGF-,p1. In all three cell lines, the TGF-,83 (but not TGF-,82) contain the fibronectin-binding sequence mRNA migrated as a species of about 3.5 kb (Fig. 4) . A faintly Arg-Gly-Asp (26) . Given the known effects of TGF-,Bl on the hybridizing band was found at 4.2 kb, which was also seen exposure. Interestingly, umbilical cord, which we had shown previously to contain multiple TGF-f3-like activities, expresses the highest level ofTGF-f33 mRNA that we have seen to date (Fig. 4) . Peptide antisera to TGF-,83 confirm that the protein is present in umbilical cord extracts in fractions containing growth inhibitory activity (K.K.I. and S. I. Rayter, unpublished data).
The TGF-fi Gene Family and Comments on Nomenclature.
During the last few years TGF-f31 and -.2 have been shown to correspond to a number of previously described biological activities; these include the glioblastoma-derived T cell suppressor factor (22) , cartilage-inducing factors A and B (27, 28) , tumor growth inhibiting factor (29) , and polyergin (originally termed BSC-1-derived growth inhibitor) (30) . Clearly, TGF-f3s are important in the regulation of cell growth. An inability of cells either to produce such inhibitory factors or to respond to them may play a critical role in transformation (7, 8) , and members of the TGF-f3 family, therefore, could function as antioncogenes.
Recently, it has become apparent that the TGF-f3s belong to an expanding family of genes, which not only act as potent regulators of cell growth but also affect cell differentiation. These genes include those that encode multiple forms of activin and inhibin, which regulate secretion of follicle-stimulating hormone (31, 32) ; the gene that encodes Mullerian inhibiting substance, responsible for regression of the female reproductive tract during development of the male embryo (33) ; Vgl, which appears to be involved in mesoderm formation during Xenopus development (34) ; and the decapentaplegic gene of Drosophila, which is associated with dorsal-ventral determination during embryogenesis (35) . Given the multiple activities exhibited by the TGF-/ gene family, we predict that our cDNA clone may also encode a protein with pleiotropic biological functions, as opposed to being strictly another TGI. Therefore, neither the term TGF-,8 nor the term TGI is appropriate for this factor. Due to the current widespread use of the former nomenclature, however, we have chosen the term TGF-f33 for present designation. As has been proposed (30), a more appropriate nomenclature for this gene family is needed. One possibility would be the use of TGF as an abbreviation for tissue growth factor. Perhaps, however, such terminology should await a clearer definition of the in vivo physiology of these factors.
Note Added in Proof. Partial cDNA clones for the chicken TGF-.83 have been isolated recently by Jakowlew et al. (36) . The predicted C-terminal 112 amino acids of chicken TGF-/3 share 111/112 residues sequence identity with the human protein described herein.
